3D-NGA52635 - 1-cyclopentyl-3-methyl-piperazine
tert-Butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate
CAS:Formula:C33H45N7O4Purity:96%Color and Shape:SolidMolecular weight:603.75494-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester
CAS:4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl esterPurity:99%Molecular weight:603.75g/mol4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester
CAS:Purity:98%Molecular weight:603.7680053710938tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)(nitroso)amino)pyridin-3-yl)piperazine-1-carboxylate
CAS:Controlled ProductFormula:C33H44N8O5Color and Shape:NeatMolecular weight:632.77tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)(nitroso)amino)pyridin-3-yl)piperazine-1-carboxylate
Controlled ProductFormula:C33H44N8O5Color and Shape:NeatMolecular weight:632.77Palbociclib isethionate
CAS:Formula:C26H35N7O6SPurity:99%Color and Shape:SolidMolecular weight:573.66446-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one hydrochloride
CAS:Formula:C24H30ClN7O2Purity:98%Color and Shape:SolidMolecular weight:483.9937Ref: IN-DA00392X
1g100.00€5g171.00€10g297.00€1mg24.00€25g619.00€5mg29.00€100gTo inquire10mg26.00€250gTo inquire50mg39.00€100mg43.00€250mg50.00€Palbociclib Impurity 9 DiHCl
CAS:Formula:C24H29N7O2·2HClColor and Shape:Yellow SolidMolecular weight:447.54 2*36.46Palbociclib Impurity 13 TriHCl
CAS:Formula:C24H29N7O2·3HClColor and Shape:Orange-Yellow SolidMolecular weight:447.54 3*36.46Palbociclib
CAS:Applications Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009);Formula:C24H29N7O2Color and Shape:NeatMolecular weight:447.53Palbociclib-d4
CAS:Controlled ProductApplications Palbociclib-d4 is an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)Formula:C24H25D4N7O2Color and Shape:Light YellowMolecular weight:451.566-Desacetyl-6-bromo-N-Boc Palbociclib-d4
CAS:Controlled ProductApplications 6-Desacetyl-6-bromo-N-Boc Palbociclib-d4 is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)Formula:C9H7F3O3Color and Shape:NeatMolecular weight:220.145Palbociclib-d4 Hydrochloride
CAS:Controlled ProductApplications Palbociclib-d4 Hydrochloride is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)Formula:C25H27D4N7O2·HClColor and Shape:NeatMolecular weight:502.04
![tert-Butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00GU6U.webp&w=3840&q=75)
![4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb-webp%2FOR82411.webp&w=3840&q=75)
![4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF788727.webp&w=3840&q=75)
![tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB201910.webp&w=3840&q=75)
![tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB202010.webp&w=3840&q=75)
![6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-on…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00392X.webp&w=3840&q=75)
